Shandong Hua'an Biotechnology Co., Ltd. was established in February 2008, registered in Laicheng Industrial Zone, Jinan City, Shandong Province, covering an area of 100 mu. It is a high-tech enterprise jointly established by domestic famous medical device listed companies and overseas investment companies, specializing in the Research and development, production and sales of minimally invasive medical devices. The company has a research and development team led by experts in the medical and polymer fields recognized in the industry, committed to the research and development of biopolymer materials and biodegradable vascular stents, and has a number of independent research and development of patent technology。

"Bioabsorbable coronary rapamycin eluting stent" is a project independently developed by our company. After eight years of hard work, we have overcome many technical difficulties, broken through a number of key technologies, and mastered the core technology mastered by only a few multinational companies in the world Frame system "(xinsorb bracket)。

The company has built a 3000m2 GMP 10000 class clean workshop and quality inspection center with a high standard, and installed a production line with an annual production capacity of 30000 degradable stents, with a total design capacity of 250000 pieces / year。

The company has been able to obtain the product registration certificate and sales license in March 2020. In 2020, it is estimated that the sales revenue will be 40 million yuan and the tax will be 12 million yuan. In 2021, the sales revenue will be 100 million yuan and the tax will be 25 million yuan. In 2022, the sales revenue will be 300 million yuan and the tax will be 80 million yuan。